Pilot Clinical Trial of CPC/rhBMP-2 Microffolds as Bone Substitute for Bone Regeneration
Sponsor: East China University of Science and Technology
A PHASE4 clinical study on Bone Fracture, this trial is completed. The trial is conducted by East China University of Science and Technology and has accumulated 6 data snapshots since 2013. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE4
-
Oct 2018 — Jan 2021 [monthly]
Completed PHASE4
-
Jun 2018 — Oct 2018 [monthly]
Completed PHASE4
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE4
First recorded
Mar 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- East China University of Science and Technology
- Shanghai 6th People's Hospital
- Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
- Shanghai Zhongshan Hospital
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.